Bart Claes

6.8k citations
37 papers · 5.7k · 2 hit papers · h-index 24

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

Bart Claes

36 papers receiving 5.5k citations

Bart Claes's Hit Papers

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial 2011 · 809 citations
8090+5+10Years since publication5001k1.5k

Peers

Bart Claes
Comparison fields: 5 of 106
  • Oncology 2.6k
  • Cancer Research 529
  • Pathology and Forensic Medicine 620
  • Immunology 384
  • Pulmonary and Respiratory Medicine 468
Replace James G. Karras with:
James G. Karras United States
Gen‐Hong Di China
W P Bennett United States
Long Cui China
Roy Garcia United States
Li‐Yuan Bai Taiwan
Zhong Chen United States
Cathy A. Finlay United States
Jeff M. Trent United States
Gloria H. Su United States
Bart Claes relative to James G. Karras United States James G. Karras's profile →
Citations per field
00.5×1.5×2.1×
James G. Karras · 1×
Citations per year

Countries citing papers authored by Bart Claes

Since Specialization
Citations

This map shows the geographic impact of Bart Claes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Claes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Claes more than expected).

Fields of papers citing papers by Bart Claes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Claes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Claes. The network helps show where Bart Claes may publish in the future.

Co-authors

The 25 scholars most cited alongside Bart Claes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart Claes Line = papers co-authored together Bart Claes links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Hit paper breakdown →
20101821
2
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Hit paper breakdown →
2011809
3 2009462
4 2009391
5 1990266
6 2009253
7 1990170
8 2012150
9 2012146
10 2011144
11 1989130
12 2013128
13 2008123
14 201392
15 201384
16 201673
17 199865
18 201263
19 201345
20 201543

About Bart Claes

Bart Claes is a scholar working on Oncology, Cancer Research, Molecular Biology, Plant Science and Pathology and Forensic Medicine, having authored 37 papers that have together received 5.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Plant Stress Responses and Tolerance (5 papers), Cancer Genomics and Diagnostics (5 papers), Renal cell carcinoma treatment (3 papers), Plant Molecular Biology Research (2 papers), Plant tissue culture and regeneration (2 papers), BRCA gene mutations in cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (529 citations), Pathology and Forensic Medicine (620 citations), Immunology (384 citations) and Pulmonary and Respiratory Medicine (468 citations). Bart Claes has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Diether Lambrechts, Allan Caplan, Rudy A. Dekeyser, Marc VAN MONTAGU, Raimundo Villarroel, Eric Van Cutsem, Ian Buysschaert, An Lehouck, Chantal Mathieu and Sabine Tejpar. Their work appears in journals such as Annals of Oncology, The Plant Cell, The Lancet Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact